Lineage Cell Therapeutics LCTX Balance Sheet (2010-2026)

NYSE LCTX
$1.09 -0.01 (-1.36%)
As of: Sep 4, 2026 · 3:15 PM EDT
Reported Financials

Lineage Cell Therapeutics Quarterly Balance Sheet

Periods 64 quarters
Latest Jun 2026

Lineage Cell Therapeutics reported total assets of $106.22M and total liabilities of $46.42M for the quarter ended Jun 2026, up 17.0% year over year. This balance sheet covers 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
60.81M55.74M78.06M70.86M24.75M50.62M15.45M33.89M31.47M35.44M43.58M29.62M27.75M45.79M47.89M42.27M40.46M45.97M45.27M43.25M
Short-term InvestmentsInvestments (Current)
4.29M2.62M1.88M1.17M41.60M46.52M31.36M12.04M9.90M0.05M0.04M8.87M4.96M2.02M0.02M0.02M0.02M14.99M17.44M13.47M
Cash & Current Investments
65.10M58.36M79.94M72.03M66.36M97.14M46.81M45.92M41.37M35.49M43.62M38.50M32.71M47.80M47.91M42.29M40.49M60.95M62.72M56.72M
Receivables - NetNet Receivables
2.12M50.64M0.32M0.53M0.43M0.30M0.17M0.44M0.43M0.74M0.08M0.23M0.41M0.64M0.21M0.26M0.13M0.89M0.81M0.79M
Receivables - OtherOther Receivables
0.54M0.20M0.55M0.58M0.55M0.67M0.58M0.17M
Receivables
2.12M51.17M0.32M0.73M0.98M0.88M0.17M0.44M0.43M0.74M0.08M0.23M0.41M0.64M0.21M0.26M0.68M1.56M1.39M0.96M
Inventory
Prepaid Assets
3.16M2.35M1.41M1.29M1.72M1.83M2.64M2.12M1.72M2.20M2.02M1.66M1.28M2.55M1.87M1.30M1.65M2.48M1.98M1.35M
Current Assets
68.34M111.55M81.87M74.03M68.51M60.00M49.66M48.49M43.48M38.44M45.72M40.39M34.40M51.00M49.98M43.84M42.26M59.16M56.16M52.97M
Non-Current Assets
Construction in Progress
Property, Plant & Equipment (Net)PP&E (Net)
4.73M4.87M4.55M3.87M4.65M5.67M5.58M5.31M4.85M2.25M2.10M2.02M2.01M2.25M2.15M2.25M2.16M2.57M2.50M2.52M
Long-Term Investments
Goodwill
10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M10.67M
Intangibles
66.14M66.14M66.14M66.14M66.14M66.14M66.14M66.14M66.14M46.56M66.14M66.14M66.14M46.54M46.54M31.70M31.70M31.70M31.70M31.70M
Goodwill & Intangibles
76.81M76.81M76.81M76.81M76.81M76.81M76.81M76.81M76.81M57.23M76.81M76.81M76.81M57.21M57.21M42.37M42.37M42.37M42.37M42.37M
Long-Term Deferred Tax
0.27M5.80M5.80M5.80M
Other Non-Current Assets
0.61M0.63M0.64M0.60M0.59M0.63M0.64M0.59M0.55M
Non-Current Assets
62.87M63.00M62.65M61.90M62.64M63.66M63.55M63.20M62.67M62.58M62.77M62.41M62.19M62.22M61.77M46.95M47.38M53.43M53.37M53.25M
Assets
131.21M174.54M144.52M135.92M131.15M123.66M113.20M111.69M106.15M101.02M108.48M102.80M96.59M113.22M111.75M90.80M89.64M112.58M109.53M106.22M
Liabilities
Current Liabilities
Accounts Payables
6.71M27.97M8.96M8.68M9.81M8.61M5.25M4.68M5.03M6.27M5.68M5.02M4.48M5.44M4.98M4.45M4.55M7.18M5.57M5.39M
Notes Payables
Payables
6.71M27.97M8.96M8.68M9.81M8.61M5.25M4.68M5.03M6.27M5.68M5.02M4.48M5.44M4.98M4.45M4.55M7.18M5.57M5.39M
Accumulated Expenses
1.64M22.09M21.00M21.00M5.00M3.83M1.81M1.92M2.25M3.12M2.48M2.22M2.49M3.07M2.08M2.16M2.54M3.74M2.74M2.85M
Other Accumulated Expenses
0.07M0.18M0.08M0.01M0.03M0.04M0.00M
Short term Debt
Current Leases
0.80M0.80M0.72M0.59M0.54M0.92M0.91M0.93M0.88M0.83M1.05M1.07M1.08M1.10M1.12M1.00M1.02M0.82M0.83M0.92M
Current Deferred Revenue
0.97M50.50M45.60M41.50M38.91M9.42M35.03M32.10M31.11M10.81M10.11M9.14M8.25M7.39M6.93M5.26M3.77M3.33M1.72M1.68M
Total Current Liabilities
8.79M47.12M24.59M25.09M22.74M18.98M17.23M16.05M15.88M17.96M16.89M15.28M13.86M13.98M13.09M10.76M9.38M11.37M8.15M8.02M
Non-Current Liabilities
Capital Leases
0.01M0.03M0.03M0.02M0.02M0.08M0.13M0.11M0.10M0.09M0.08M0.07M0.08M0.07M0.05M0.05M0.04M0.03M0.02M0.01M
Non-Current Debt
Convertible Debt
Non-Current Deffered Revenue
32.45M30.82M25.77M26.54M27.73M24.02M21.69M21.20M18.69M18.18M18.54M16.05M14.43M13.61M12.75M12.46M12.38M13.00M12.34M
Minority Interest
-1.12M-1.32M-1.33M-1.35M-1.40M-1.40M-1.44M-1.41M-1.46M-1.40M-1.41M-1.43M-1.39M-1.37M-1.37M-1.27M-1.24M-1.20M-1.18M-1.12M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
0.89M2.08M2.08M2.08M2.08M2.08M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.02M0.02M0.02M
Operating Leases
1.89M1.94M1.78M2.05M2.22M2.86M2.54M2.30M2.05M1.98M2.07M1.77M1.53M1.29M1.01M1.06M1.51M1.53M1.51M1.33M
Other Non-Current Liabilities
0.03M0.01M0.00M0.00M0.00M0.00M0.00M6.16M6.06M18.80M45.17M43.91M34.14M24.70M
Total Non-Current Liabilities
83.62M59.30M54.42M53.59M51.73M44.19M40.43M39.00M30.05M28.04M24.89M23.67M25.33M22.70M21.73M
Total Liabilities
11.62M83.65M59.30M54.42M53.59M51.73M44.19M40.43M39.49M39.00M37.49M35.93M31.80M36.21M34.10M43.69M68.84M69.24M56.84M46.42M
Shareholder's Equity
Total Debt
Common Equity
119.59M90.90M85.22M81.50M77.55M71.94M69.02M71.26M450.00M62.02M70.99M66.88M64.79M77.01M77.66M47.11M22.04M44.55M52.70M60.92M
Liabilities and Shareholders Equity
131.21M174.54M144.52M135.92M131.15M123.66M113.20M111.69M106.15M101.02M108.48M102.80M96.59M113.22M111.75M90.80M89.64M112.58M109.53M106.22M
Treasury Shares
Retained Earnings
-308.11M-337.10M-344.18M-350.95M-357.02M-363.37M-367.74M-372.97M-380.08M-384.86M-391.40M-397.16M-400.19M-403.46M-407.60M-438.07M-467.85M-467.00M-471.81M-470.33M
Preferred Shares